GCC 1366: Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese Patients
University of Maryland, Baltimore
University of Maryland, Baltimore
Cancer Trials Ireland
Centre Oscar Lambret
Centre Oscar Lambret
Centre Oscar Lambret
Thomas Jefferson University
Ramsay Générale de Santé
Mayo Clinic
AHS Cancer Control Alberta
Stanford University
University of Southern California
University of Southern California
Palleos Healthcare GmbH
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Thomas Jefferson University
Thomas Jefferson University
Johns Hopkins University
University of Michigan Rogel Cancer Center
University of Utah
Centre Georges Francois Leclerc
Aarhus University Hospital
Fred Hutchinson Cancer Center
Albert Einstein College of Medicine
Wake Forest University Health Sciences
Institut Cancerologie de l'Ouest
University of Nebraska
Nova Scotia Health Authority
University Medical Center Groningen
Washington University School of Medicine
University Hospital, Montpellier
Merit Medical Systems, Inc.
Washington University School of Medicine
Institut Curie
Vanderbilt-Ingram Cancer Center
Institut Curie
Dana-Farber Cancer Institute
Alpha Tau Medical LTD.
Beth Israel Deaconess Medical Center
Maimonides Medical Center
University of Nebraska
University of South Carolina
Centre Jean Perrin
University of Washington
Centre Hospitalier Universitaire de Besancon
Centre Georges Francois Leclerc
Rutgers, The State University of New Jersey
UNC Lineberger Comprehensive Cancer Center
University of Southern California
Institut Cancerologie de l'Ouest